1/5
08:02 am
rare
Rating for RARE
Low
Report
Rating for RARE
1/5
08:02 am
rare
Rating for RARE
Low
Report
Rating for RARE
12/30
12:55 pm
rare
Rating for RARE
Low
Report
Rating for RARE
12/30
12:53 pm
rare
Rating for RARE
Low
Report
Rating for RARE
12/30
12:53 pm
rare
Rating for RARE
Low
Report
Rating for RARE
12/30
07:50 am
rare
Rating for RARE
High
Report
Rating for RARE
12/30
07:50 am
rare
Rating for RARE
High
Report
Rating for RARE
12/30
07:41 am
rare
Rating for RARE
High
Report
Rating for RARE
12/30
07:41 am
rare
Rating for RARE
High
Report
Rating for RARE
11/24
09:40 am
rare
Rating for RARE
Low
Report
Rating for RARE
11/24
09:40 am
rare
Rating for RARE
Low
Report
Rating for RARE
10/20
08:14 am
rare
Ultragenyx Pharmaceutical (NASDAQ:RARE) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $65.00 price target on the stock.
Medium
Report
Ultragenyx Pharmaceutical (NASDAQ:RARE) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $65.00 price target on the stock.